Chemomab Completes Merger with Anchiano Therapeutics

(READ MORE)

– Shares of Chemomab Therapeutics to commence trading on the Nasdaq Capital Market on March 17, 2021 under the new ticker symbol “CMMB

– Combined company will focus on advancing Chemomab’s CM-101 currently in Phase 2 for rare fibrotic indications. Visit Chemomab online at www.chemomab.com